ROA of Rite Aid Corporation (NYSE:RAD) stands at 0.8

Posted February 17, 2017

The Company has 52-week high of $8.77 and 52-week low of $5.2. John T. Standley is one of the biggest insider owners in Rite Aid Corporation (NYSE:RAD), according to U.S. Securities and Exchange Commission (SEC) filings.

A number of other institutional investors also recently modified their holdings of RAD. The company has the market capitalization of $25.38 Billion. The Average Volume of the company is 23.6 Million and P/E (price to earnings) ratio is 67.33, while Forward P/E ratio is 50.79. APG Asset Management N.V. increased its position in shares of Rite Aid Corporation by 49.8% in the second quarter. Donley Douglas E now owns 48,779 shares in the company after this transaction. Advisor Group Inc. boosted its position in Rite Aid Corporation by 2.1% in the third quarter. The Company now has Insider ownership of 0.7 Percent and Institutional Ownership of 61.8 Percent. Its share price has decline -20.25% in three months and is up 8.63% for the last five trades. Beta factor was calculated at 1.87. According to their predictions High & Low revenue estimates are 8.36 Billion and 8.25 Billion respectively. Buy rating has been given by 0 analysts to the company stock whereas no analyst given UNDERPERFORM rating to stock and 4 analysts given HOLD rating. The Return on Equity (ROE) value stands at 14.9%. Therefore, the stated figure displays a quarterly performance of -20.25% and year to date performance of -29.73%. The difference between the expected and actual EPS was $-0.03/share, which represents an Earnings surprise of -75%. "Our strategy to focus on sustainable and differentiated innovation assisted drive 28% year-on-year revenue growth, and our laser focus on operational execution drove strong year-on-year margin expansion and cash generation in the first quarter". 6 Analysts reported that the Price Target for Rite Aid Corporation might touch $9 high while the Average Price Target and Low price Target is $7.75 and $6.5 respectively. Einhorn owned slightly less than 20.5 million shares as of December 31, according to several media reports. Zacks Investment Research upgraded Rite Aid Corporation from a "sell" rating to a "hold" rating in a research report on Tuesday, November 15th. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/02/14/rite-aid-corporation-rad-shares-sold-by-sii-investments-inc-wi.html. Taking a look into the performance of RAD stock, investor will come to know that the weekly performance for this stock is valued at 8.63%, resulting in a performance for the month at -33.22%. The 7 stock analysts following this company have an average price target at $7.75, with individual PT in the $6.50-$9.00 range. Naloxone is also available for purchase without patient specific prescriptions at Rite Aid pharmacies in 17 additional states including: Alabama, California, Colorado, Connecticut, Idaho, Indiana, Kentucky, Massachusetts, Maryland, North Carolina, New Hampshire, New York, Ohio, Oregon, Pennsylvania, Rhode Island and Vermont. The Company's segments include Retail Pharmacy and Pharmacy Services. Rite Aid is also working to expand its naloxone dispensing program in other states served by the Company where naloxone is now only available with a prescription. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia.